233 related articles for article (PubMed ID: 8604546)
1. Mechanisms for persistence of acute and chronic feline calicivirus infections in the face of vaccination.
Pedersen NC; Hawkins KF
Vet Microbiol; 1995 Nov; 47(1-2):141-56. PubMed ID: 8604546
[TBL] [Abstract][Full Text] [Related]
2. Comparison of the ability of feline calicivirus (FCV) vaccines to neutralise a panel of current UK FCV isolates.
Porter CJ; Radford AD; Gaskell RM; Ryvar R; Coyne KP; Pinchbeck GL; Dawson S
J Feline Med Surg; 2008 Feb; 10(1):32-40. PubMed ID: 17720588
[TBL] [Abstract][Full Text] [Related]
3. Temporally separated feline calicivirus isolates do not cluster phylogenetically and are similarly neutralised by high-titre vaccine strain FCV-F9 antisera in vitro.
Smith SL; Afonso MM; Pinchbeck GL; Gaskell RM; Dawson S; Radford AD
J Feline Med Surg; 2020 Jun; 22(6):602-607. PubMed ID: 31411533
[TBL] [Abstract][Full Text] [Related]
4. Genogrouping of vaccine breakdown strains (VBS) of feline calicivirus in Japan.
Ohe K; Sakai S; Takahasi T; Sunaga F; Murakami M; Kiuchi A; Fukuyama M; Furuhata K; Hara M; Ishikawa Y; Taneno A
Vet Res Commun; 2007 May; 31(4):497-507. PubMed ID: 17225086
[TBL] [Abstract][Full Text] [Related]
5. Modified-Live Feline Calicivirus Vaccination Reduces Viral RNA Loads, Duration of RNAemia, and the Severity of Clinical Signs after Heterologous Feline Calicivirus Challenge.
Spiri AM; Riond B; Stirn M; Novacco M; Meli ML; Boretti FS; Herbert I; Hosie MJ; Hofmann-Lehmann R
Viruses; 2021 Jul; 13(8):. PubMed ID: 34452370
[TBL] [Abstract][Full Text] [Related]
6. Characterization of an avirulent FCV strain with a broad serum cross-neutralization profile and protection against challenge of a highly virulent vs feline calicivirus.
Rong S; Lowery D; Floyd-Hawkins K; King V
Virus Res; 2014 Aug; 188():60-7. PubMed ID: 24685673
[TBL] [Abstract][Full Text] [Related]
7. A multi-national European cross-sectional study of feline calicivirus epidemiology, diversity and vaccine cross-reactivity.
Afonso MM; Pinchbeck GL; Smith SL; Daly JM; Gaskell RM; Dawson S; Radford AD
Vaccine; 2017 May; 35(20):2753-2760. PubMed ID: 28389099
[TBL] [Abstract][Full Text] [Related]
8. Immunisation with a combination of two complementary feline calicivirus strains induces a broad cross-protection against heterologous challenges.
Poulet H; Brunet S; Leroy V; Chappuis G
Vet Microbiol; 2005 Mar; 106(1-2):17-31. PubMed ID: 15737470
[TBL] [Abstract][Full Text] [Related]
9. Neutralizing feature of commercially available feline calicivirus (FCV) vaccine immune sera against FCV field isolates.
Hohdatsu T; Sato K; Tajima T; Koyama H
J Vet Med Sci; 1999 Mar; 61(3):299-301. PubMed ID: 10331208
[TBL] [Abstract][Full Text] [Related]
10. A dual-strain feline calicivirus vaccine stimulates broader cross-neutralization antibodies than a single-strain vaccine and lessens clinical signs in vaccinated cats when challenged with a homologous feline calicivirus strain associated with virulent systemic disease.
Huang C; Hess J; Gill M; Hustead D
J Feline Med Surg; 2010 Feb; 12(2):129-37. PubMed ID: 19836282
[TBL] [Abstract][Full Text] [Related]
11. Intranasal immunization with inactivated feline calicivirus particles confers robust protection against homologous virus and suppression against heterologous virus in cats.
Sato H; Sehata G; Okada N; Iwamoto K; Masubuchi K; Kainuma R; Noda T; Igarashi T; Sawada T; Noro T; Oishi E
J Gen Virol; 2017 Jul; 98(7):1730-1738. PubMed ID: 28691897
[TBL] [Abstract][Full Text] [Related]
12. Serological analysis and identification of feline calicivirus strains isolated in Sicily.
Camero M; Cirone F; Bozzo G; Pennisi MG; Carelli G; Rinaldo D; Buonavoglia D
New Microbiol; 2002 Apr; 25(2):243-6. PubMed ID: 12019733
[TBL] [Abstract][Full Text] [Related]
13. FCV-VBS isolated from cats with typical symptoms caused VSD in experimental cats.
Ohe K; Takahashi T; Hara D; Hara M
Vet Res Commun; 2008 Feb; 32(2):145-58. PubMed ID: 17899424
[TBL] [Abstract][Full Text] [Related]
14. Ability of vaccine strain induced antibodies to neutralize field isolates of caliciviruses from Swedish cats.
Wensman JJ; Samman A; Lindhe A; Thibault JC; Berndtsson LT; Hosie MJ
Acta Vet Scand; 2015 Dec; 57():86. PubMed ID: 26655039
[TBL] [Abstract][Full Text] [Related]
15. Feline calicivirus strains isolated in Italy.
Rinaldo D; Foti M; Bottari T; Fisichella V; Buonavoglia D
Pol J Vet Sci; 2008; 11(4):359-61. PubMed ID: 19227135
[TBL] [Abstract][Full Text] [Related]
16. Long-term immunity in cats vaccinated with an inactivated trivalent vaccine.
Scott FW; Geissinger CM
Am J Vet Res; 1999 May; 60(5):652-8. PubMed ID: 10328440
[TBL] [Abstract][Full Text] [Related]
17. Three-year duration of immunity for feline herpesvirus and calicivirus evaluated in a controlled vaccination-challenge laboratory trial.
Jas D; Frances-Duvert V; Vernes D; Guigal PM; Poulet H
Vet Microbiol; 2015 May; 177(1-2):123-31. PubMed ID: 25824128
[TBL] [Abstract][Full Text] [Related]
18. Ability of antibodies to two new caliciviral vaccine strains to neutralise feline calicivirus isolates from the UK.
Addie D; Poulet H; Golder MC; McDonald M; Brunet S; Thibault JC; Hosie MJ
Vet Rec; 2008 Sep; 163(12):355-7. PubMed ID: 18806279
[TBL] [Abstract][Full Text] [Related]
19. Application of chimeric feline foamy virus-based retroviral vectors for the induction of antiviral immunity in cats.
Schwantes A; Truyen U; Weikel J; Weiss C; Löchelt M
J Virol; 2003 Jul; 77(14):7830-42. PubMed ID: 12829823
[TBL] [Abstract][Full Text] [Related]
20. Assembly of feline calicivirus-like particle and its immunogenicity.
Di Martino B; Marsilio F; Roy P
Vet Microbiol; 2007 Feb; 120(1-2):173-8. PubMed ID: 17126499
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
